Rx only · Kit
Adalimumab-Afzb
Brands: Abrilada
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | unknown | 4 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 9, 2025RESOLVEDShortage resolved: Adalimumab-afzb Injection (Pfizer Inc.)
Adalimumab-afzb Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Rheumatology.
- Oct 9, 2025SHORTAGEDrug shortage: Adalimumab-afzb Injection (Pfizer Inc.)
Adalimumab-afzb Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Rheumatology.
Pill